NYU Langone Health in the News—May 30, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from May 30, 2025.
mind-matters-fall-winter-2024-2025.pdf
... D continued on next page On July 2, 2024, the US Food and Drug Administration approved donanemab, making ... to safely add this medication to our formulary in the near future. SECTION 2 What Is Vascular Dementia? By ...
NYULH–InternsFAQ–DigFlyer–8.5x11-251024-v01
... and HCC9 (the medically complex unit). b. For pediatric interns: Pediatric interns complete two main ... medical insurance? How much is it? a. Once you are onboarded, you’ll have access to an internal website ...
trauma-systems-therapy-2025-1.pdf
... of traumatic stress. For more information, see page 3. The majority of children/youth/families involved ... for children, youth, and families available in Spanish. Learn more on page 4. ■ For more information explore ...
NYU Langone Health in the News— Friday 11, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from July 11, 2025.
EPA 1a-BR Worksheet
... to Domains of Competence X Patient Care X Medical Knowledge X Systems-Based Practice X Practice ...
Epidemiology Follow Up Questionnaire 1998-2003
... : 19 2/98 DC 04/16/2019 -- -- 4. Did a doctor ever tell you that you had any of the medical problems ... ever have cancer of the colon or rectum? NoD YesD PLEASE TURN THIS PAGE OVER DC 04/16/2019 16. In what ...
New Hospital Pavilion with Pediatric Hospital Facility Opens
NYU Langone adds to New York City’s healthcare space with the Helen L. and Martin S. Kimmel Pavilion and Hassenfeld Children’s Hospital.
NYU Langone Health in the News—October 30, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from October 30, 2025.
NYU Langone Scientists are Developing a Vaccine to Cure HIV
NYU Langone scientist and renowned researcher Nathaniel R. Landau, PhD, is developing a therapeutic vaccine to treat HIV-infected patients.